siRNA, Anti-CDK16, 2'-F/2'-OMe/2'-MOE/LNA/Backbone-modified(CAT#: SIRGT16255WQ-2OMe)

The product SIRGT16255WQ-2OMe is a type of small interfering RNA (siRNA) that targets CDK16 gene and regulates the expression of gene. The siRNA interferes with the expression of CDK16 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001170460.1; NM_006201.4; NM_033018.3
Alternative Names PCTAIRE; PCTAIRE1; PCTGAIRE; PCTK1
Related Diseases DNA Damage
Purification HPLC
Target Gene
Gene ID 5127
Uniprot ID Q00536
Sub Cat Target Species Modification Scale  
SIRGT17255WQ-2F CDK16 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT18255WQ-2MOE CDK16 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT19255WQ-LNA CDK16 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT17255WQ-BB CDK16 Human Backbone-modified Inquiry

Related Products